# Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer

> **NCT05007444** · PHASE2 · UNKNOWN · sponsor: **Hospital Universitario San Ignacio** · enrollment: 58 (estimated)

## Conditions studied

- Breast Cancer
- Quality of Life
- Tumor, Breast

## Interventions

- **DRUG:** P2Et (Caesalpinia spinosa extract)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05007444
- **Lead sponsor:** Hospital Universitario San Ignacio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-30
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2022-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007444, "Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05007444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*